Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

    NEXT STORY
    Report from extraordinary general meeting in Active Biotech and adjustment of previously communicated timetable for the rights issue
    PREV STORY
    Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Rare Disease Diagnostics Market to 2025: Market was Valued $45.18 Billion in 2017 and is Anticipated to Reach $86.15 Billion

    Dublin, Nov. 12, 2018 (GLOBE NEWSWIRE) -- The "Global Rare Disease Diagnostics Market: Focus ...

    author_avatar
    NASDAQ Market News

    Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Saudi Arabia by Hikma Pharmaceuticals LLC

    Basel, Switzerland, May 15, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that ...

    author_avatar
    NASDAQ Market News

    Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™

    author_avatar
    NASDAQ Market News